Adimmune (TPE:4142) Moat Score: 0/10 (As of Jul. 04, 2026)


TPE:4142 Adimmune Corp TPE:4142
54 GF Score
Price NT$17.80
GF Value NT$25.53
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adimmune Moat Score?

Adimmune has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Adimmune has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Adimmune might have No Moat - No discernible moat.

Adimmune  (TPE:4142) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Adimmune Moat Score Related Terms

TPE:4142
54GF Score
Adimmune Corp TPE:4142
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$17.80 is trading 30.3% below its estimated GF Value™ of NT$25.53. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

  • Moat Score: 0
  • GF Value™: NT$25.53 vs. price of NT$17.80 (30.3% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
54GF Score

Get the complete analysis for TPE:4142

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.80
Price
NT$25.53
GF Value